47,586 Shares in Inspire Medical Systems, Inc. (NYSE:INSP) Purchased by Jennison Associates LLC

Jennison Associates LLC bought a new stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 47,586 shares of the company's stock, valued at approximately $8,821,000. Jennison Associates LLC owned approximately 0.16% of Inspire Medical Systems as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. The Manufacturers Life Insurance Company lifted its position in shares of Inspire Medical Systems by 0.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 21,193 shares of the company's stock valued at $2,836,000 after buying an additional 92 shares in the last quarter. Creative Planning lifted its holdings in Inspire Medical Systems by 12.4% during the second quarter. Creative Planning now owns 2,575 shares of the company's stock valued at $345,000 after purchasing an additional 284 shares in the last quarter. Cetera Investment Advisers boosted its position in shares of Inspire Medical Systems by 497.7% in the second quarter. Cetera Investment Advisers now owns 17,512 shares of the company's stock worth $2,344,000 after purchasing an additional 14,582 shares during the period. Handelsbanken Fonder AB increased its stake in shares of Inspire Medical Systems by 12.0% in the third quarter. Handelsbanken Fonder AB now owns 8,400 shares of the company's stock worth $1,773,000 after purchasing an additional 900 shares in the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Inspire Medical Systems by 559.3% during the 3rd quarter. GAMMA Investing LLC now owns 178 shares of the company's stock valued at $38,000 after purchasing an additional 151 shares during the period. Institutional investors own 94.91% of the company's stock.

Inspire Medical Systems Trading Up 0.4 %

INSP traded up $0.79 during trading hours on Friday, hitting $182.00. The company's stock had a trading volume of 481,109 shares, compared to its average volume of 564,408. Inspire Medical Systems, Inc. has a 12 month low of $123.00 and a 12 month high of $257.40. The business's 50-day moving average price is $189.72 and its 200-day moving average price is $190.31. The stock has a market cap of $5.45 billion, a price-to-earnings ratio of 170.10 and a beta of 1.32.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. KeyCorp reaffirmed an "overweight" rating and issued a $234.00 target price (down previously from $236.00) on shares of Inspire Medical Systems in a report on Friday, January 24th. Wells Fargo & Company upped their price objective on Inspire Medical Systems from $187.00 to $198.00 and gave the stock an "equal weight" rating in a research note on Tuesday, November 5th. Bank of America raised Inspire Medical Systems from a "neutral" rating to a "buy" rating and lifted their target price for the company from $220.00 to $255.00 in a research note on Wednesday, November 20th. Royal Bank of Canada restated an "outperform" rating and issued a $260.00 price target on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Finally, Robert W. Baird lifted their price objective on shares of Inspire Medical Systems from $240.00 to $252.00 and gave the company an "outperform" rating in a research report on Tuesday, November 5th. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, Inspire Medical Systems currently has an average rating of "Moderate Buy" and an average target price of $231.45.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.